Massimo Puoti
Publications by Year
Research Areas
Hepatitis C virus research, Liver Disease Diagnosis and Treatment, Hepatitis B Virus Studies, HIV/AIDS drug development and treatment, HIV Research and Treatment
Most-Cited Works
- → EASL Recommendations on Treatment of Hepatitis C 2018(2018)2,828 cited
- → Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection(2014)1,699 cited
- → EASL recommendations on treatment of hepatitis C: Final update of the series☆(2020)1,185 cited
- → Statements from the Taormina expert meeting on occult hepatitis B virus infection(2008)816 cited
- → A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma(1998)542 cited
- → Update of the statements on biology and clinical impact of occult hepatitis B virus infection(2019)534 cited
- → Glecaprevir–Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 Infection(2018)430 cited
- → A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel(2011)406 cited
- → Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials(2018)373 cited
- → Care of patients coinfected with HIV and hepatitis C virus: 2007 updated recommendations from the HCV–HIV International Panel(2007)347 cited